$SYM

KANE CHARLES sold $86K of SYM

KANE CHARLES sold 2,000 shares of Symbotic Inc. (SYM) at $43.21 on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · KANE CHARLES
Published Aug 5, 2026, 9:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 9:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SYM
Neutral
high confidence
Mentioned
$SYM
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SYMNeutralLow
01

Why it matters

The disclosed event is an open-market sale of 2,000 shares at $43.21, totaling $86,420, executed under a pre-arranged Rule 10b5-1 plan. The text contains no additional company developments.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the 10b5-1 framing and lack of new fundamentals make it low-impact for trading decisions.

03

What to watch

The article provides only the sale details; it does not state whether the director’s overall position is changing materially over time, nor does it include any company-specific news that could contextualize the sale.

Relevance 2/10Novelty 2/10Timing: filed 2026-08-05 after-hours; transaction dated 2026-08-03

Background

The article is a SEC Form 4 insider transaction disclosure for Symbotic Inc., reported by director Kane Charles.

Company-level read

Ticker impact

$SYMNeutralHigh confidence
Context

Director Kane Charles filed a Form 4 showing an open-market sale of 2,000 Symbotic shares at $43.21 on 2026-08-03 under a 10b5-1 plan.

Expected impact

Low near-term impact; any effect is likely sentiment-only and should fade unless accompanied by other disclosures.

Evidence & confidence

The filing is an insider transaction (not a buy), explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying operational, financial, or regulatory catalyst in the text.

Market effects

No sector read-through provided; insider sale does not change Symbotic’s competitive or demand outlook in the article.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with perceived valuation risk, so traders may watch for follow-on sales or buys in subsequent filings.

Key entities

  • Symbotic Inc.

    Subject of the Form 4 insider transaction disclosure (SYM).

  • Kane Charles

    Director who reported the sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SYMMed

Symbotic director Charles Kane sells $78,000 of Class A stock

Symbotic Inc. director Charles Kane sold 2,000 shares of Class A stock for $78,000 at $39 per share on September 1, 2026. The stock currently trades at $41.60, down 30% year-to-date. Symbotic reported Q3 revenue of $721 million, up 22% YoY, and adjusted EBITDA of $95 million, more than double the previous year. Despite strong results, the stock declined in after-hours trading due to concerns over future margins and outlook.

$NBISMed

3 Growth Stocks to Buy Before Wall Street Catches On

Nebius (NBIS) reported 454% revenue growth and a $37.5B backlog, with Meta and NVIDIA deals. Symbotic (SYM) trades near 52-week lows despite a $22.5B backlog. Centrus Energy (LEU) beat Q2 EPS by 93% with a $4.5B backlog. All three companies show high growth but trade below consensus targets.

$SYMMed

What’s Really Behind Symbotic’s (SYM) Big Quarter?

Symbotic Inc. (NASDAQ:SYM) reported fiscal Q3 revenue of $721M, up 22% year over year, with net income of $55M versus a $21M loss a year earlier. Adjusted EBITDA rose to $95M. The company said 11 new deployments brought totals to 77 in deployment. Shares face a high forward P/E (238.1) and 28.1% short interest.

$OUSTMed

Robotics Stocks Rally as Unitree’s 8000X Oversubscribed IPO Draws Frenzied Demand: Ouster, Symbotic, and Teradyne in Focus

Robotics and physical AI stocks rose after China’s Unitree Robotics Shanghai IPO reportedly drew 8,000x retail oversubscription. In U.S. trading, Ouster gained 7% near $45, Symbotic rose 3% to about $41, and Teradyne added 3% to about $376. Ouster reported Q2 revenue of $54.63M (+55.9% YoY) and 17,000+ sensors; Symbotic has a ~$22.5B backlog. Analysts’ consensus targets cited $58 for OUST and $450 for TER.

$SYMHigh

Symbotic Inc. (SYM): Results of Operations and Financial Condition

Symbotic Inc. (SYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Symbotic Reports Third Quarter Fiscal Year 2026 Results Steve Pagliuca, Former Co-Chair of Bain Capital, Elected to Symbotic’s Board of Directors Wilmington, Massachusetts (August 5, 2026) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled